Intellectual Property India Publishes Patent Application for Engineered Dxp Pathway For Improved Isoprenoid Production In E. Coli

MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617098797 A) filed by Bp Corporation North America Inc. on August 14, 2026, for Engineered Dxp Pathway For Improved Isoprenoid Production In E. Coli.

Inventors include Valle, Fernando; Tohidifar, Payman; Najdi, Tarek; and Vu, Huong Nguyen Nhu.

The application for the patent was published on October 30, 2026, under issue no. 44/2026.

Abstract: The present disclosure relates to recombinant microorganisms, such as bacteria, e.g., E. coli, engineered to have improved flux and/or yield of the DXP pathway. Cells can be engineered to comprise nucleotide sequences comprising dxs polypeptides (EC 2.2.1.7); dxr polypeptides (EC 1.1.1.267); ispD polypeptides...